Big Blog

Arts & Culture
Banking
Biological Science
Blog Watch
Celebrities
Computer Games
Computer Security
Cricket
Data Privacy
Developer
Domain Names
E-commerce
Gadgets
General Science
Handhelds
IP & Patents
Java
Linux
Mobile Technology
Movie Reviews
MP3
Nanotech
Online Auctions
Online Legal Issues
Open Source
Personal Finance
Photography
Quirky
Robotics
Search Engines
Space Science
Top Internet
Top Stories
Top Tech
Video Games
Web Developer
Webmaster Tips
XML & Metadata
{Home}



generics: search

BIG PHARMA AND GENERICS DUKE IT OUT AT THE SUPREME COURT OVER SELECTION PATENTS

Billions of dollars are at stake as generic drug companies and inventors battle over the doctrine of selection patents. The effect on the country’s pharmaceutical scene could be profound

Brand Names Take On Generics In PSU Showdown

The Raindog writes "The power supply is perhaps the most overlooked element of a modern PC, and yet it's the one component that can irreparably damage the rest of a system. The market is littered with generic PSUs that are often much cheaper than name-brand alternatives, but can you trust them? The Tech Report aims to find out in its latest power supply round-up, which compares the performance, efficiency, and noise levels of a collection of reputable PSUs with some budget, no-name competition. As it turns out, any money you save on a generic PSU purchase will likely cost you more in the long run."

Glenmark confirms patent challenge of fluticasone lotion

MUMBAI: Glenmark Generics Ltd's US subsidiary confirmed Nycomed US filed a patent infringement lawsuit on Dec 12, 2008, in the US District Court, Eastern District Court of New York regarding Glenmark's abbreviated new drug application for its fluticasone propionate 0.05% lotion product. Nycomed currently markets its fluticasone product as cutivate.

Glenmark confirms patent challenge by Nycomed

Singapore, Dec19, 2008: Glenmark Generics’ US subsidiary (GGI) has confirmed that Nycomed US has filed a patent infringement lawsuit on December 12

Judge warns Commission over patent changes

A UK judge has warned against the European Commission making rash changes following its report into big pharma blocking generics, arguing that it could damage development of new drugs.

King Sues Sandoz Over Patent For Muscle Relaxant

Law360, New York (December 08, 2008) -- King Pharmaceuticals Inc., the exclusive licensee of the muscle relaxant Skelaxin, has sued generics maker Sandoz Inc. over Sandoz's plan to make and market a generic version of the drug.


Search News:


Copyright © 2001-2008 Jonathan Hedley